ArticleNPJ precision oncology2026

HAMNO and CGK733 as BRCAness-driven candidates exhibit synthetic lethality with olaparib in BRCA-proficient ovarian cancer.

Yashuang Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.